<!DOCTYPE html>

<html lang="en"><head>
<meta content="text/html; charset=utf-8" http-equiv="content-type"/>
<meta charset="utf-8"/>
<meta content="IE=edge" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>Sample Reports</title>
<style>
    table {
      border-collapse: collapse;
      width: 100%;
    }

    th,
    td {
      border: 1px solid black;
      padding: 8px;
      text-align: left;
    }

    th {
      background-color: #f2f2f2;
    }

    tr:nth-child(even) {
      background-color: #f2f2f2;
    }

  </style>
</head>
<body><h1>MR PROSTATE</h1><table>
<tbody>
<tr><td bgcolor="#ababab">Free Text</td><td ,="" bgcolor="#ededed" style="white-space: word-wrap;">MRI
 ABDOMEN AND PELVIS FOR EVALUATION OF THE PROSTATECLINICAL HISTORY: The 
patient is a 60-year-old male with a history of prostate cancer and 
elevated PSA. The multiparametric prostate MRI was performed to monitor 
the known prostate cancer. TECHNIQUE: Multiplanar, multisequence MRI of 
the abdomen and pelvis was performed, including diffusion, T2, and 
dynamic contrast-enhanced (DCE) imaging of the prostate. The 
post-contrast images were obtained following the uneventful intravenous 
administration of 8 mL of gadobutrol (Gadavist) gadolinium-containing 
contrast. COMPARISON: ( )FINDINGS: The prostate gland is mildly enlarged
 measuring 4.2 x 4.8 x 4.7 cm (volume 42 mL). There are no suspicious 
lesions or abnormal signal intensity in the peripheral zone of the 
prostate gland. However, a small focal area of low T2 signal intensity 
is seen in the right transition zone measuring approximately 6 mm in 
diameter, which has increased in size compared to the prior study. The 
area shows restricted diffusion on the ADC map, with a value of 912 x 
10^-3 mm^2/s. In addition, there is a focal area of T2 hypointensity in 
the left base peripheral zone, measuring approximately 7 mm in diameter,
 which has remained stable. The ADC value for this area is 1235 x 10^-3 
mm^2/s. The dynamic contrast-enhanced (DCE) characteristics show 
diffusely enhancing area with plateau-type kinetics in the right 
transition zone, with a PI-RADS v2 score of 4. On the other hand, the 
left base peripheral zone has mildly enhancing area with gradual wash-in
 and washout kinetics, with a PI-RADS v2 score of 3. IMPRESSION: Based 
on the above findings, there is no evidence of suspicious lesions or 
significant changes in the peripheral zone of the prostate gland 
compared to the prior study. However, the small focal area of low T2 
signal intensity in the right transition zone has increased in size 
compared to the prior study, with a PI-RADS v2 score of 4. This suggests
 a possible progression of the previously diagnosed prostate cancer in 
the right transition zone, requiring further evaluation and monitoring. 
The patient will be advised for additional biopsy and follow-up by their
 urologist.</td></tr>
<tr><td bgcolor="#ababab">Structured</td><td ,="" bgcolor="#ffffff" style="white-space: pre-wrap; word-wrap: break-word;"><table border="1"><tbody><tr><th>INDICATION</th><td><table border="1"><tbody><tr><th>DATE</th><td></td></tr><tr><th>SERUM PSA LEVEL</th><td></td></tr><tr><th>PRIOR BIOPSY</th><td><table border="1"><tbody><tr><th>TYPE</th><td></td></tr><tr><th>DATE</th><td></td></tr><tr><th>RESULTS</th><td></td></tr></tbody></table></td></tr><tr><th>PRIOR THERAPY</th><td><table border="1"><tbody><tr><th>RADIATION</th><td></td></tr><tr><th>HORMONES</th><td></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>TECHNIQUE</th><td><table border="1"><tbody><tr><th>PI RADS COMPLIANT</th><td></td></tr><tr><th>FIELD STRENGTH</th><td></td></tr><tr><th>COILS USED</th><td></td></tr><tr><th>IV CONTRAST ADMINISTRATION</th><td><table border="1"><tbody><tr><th>ROUTE</th><td>intravenous</td></tr><tr><th>RATE</th><td></td></tr></tbody></table></td></tr><tr><th>PULSE SEQUENCE PARAMETERS</th><td>Multiplanar, multisequence MRI of the abdomen and pelvis, including diffusion, T2, and dynamic contrast-enhanced (DCE) imaging of the prostate.</td></tr></tbody></table></td></tr><tr><th>COMPARISON</th><td>prior study</td></tr><tr><th>FINDINGS</th><td><table border="1"><tbody><tr><th>QUALITY</th><td></td></tr><tr><th>PERIPHERAL ZONE</th><td>No suspicious lesions or abnormal signal intensity</td></tr><tr><th>TRANSITION ZONE</th><td>Small focal area of low T2 signal intensity in the right transition zone</td></tr><tr><th>LESIONS</th><td><table border="1"><thead><tr><th>HEMORRHAGE</th><th>RANK</th><th>ZONE</th><th>SIDE</th><th>POSITION</th><th>IMAGE SERIES NUMBER</th><th>LENGTH</th><th>WIDTH</th><th>HEIGHT</th><th>VOLUME</th><th>PSA DENSITY</th><th>EXTRA PROSTATIC EXTENSION</th><th>PI RADS CATEGORY</th></tr></thead><tbody><tr><td></td><td></td><td>right transition zone</td><td>right</td><td></td><td></td><td>6 mm</td><td></td><td></td><td></td><td></td><td></td><td>4</td></tr></tbody></table></td></tr><tr><th>NEUROVASCULAR BUNDLES</th><td><table border="1"><tbody><tr><th>IMPRESSION</th><td></td></tr><tr><th>DISTANCE FROM INDEX LESION</th><td></td></tr></tbody></table></td></tr><tr><th>SEMINAL VESICLES</th><td></td></tr><tr><th>LYMPH NODES</th><td></td></tr><tr><th>BONES</th><td></td></tr><tr><th>OTHER PELVIC ORGANS</th><td></td></tr></tbody></table></td></tr><tr><th>IMPRESSION</th><td><table border="1"><thead><tr><th>LESION NUMBER</th><th>OVERALL PI RADS CATEGORY</th></tr></thead><tbody><tr><td>1</td><td>4</td></tr></tbody></table></td></tr></tbody></table></td></tr>
<tr><td bgcolor="#ababab">Free Text</td><td ,="" bgcolor="#ededed" style="white-space: word-wrap;">MRI
 ABDOMEN AND PELVIS FOR EVALUATION OF THE PROSTATECLINICAL HISTORY: The 
patient is a 66-year-old male with elevated PSA levels and a history of 
prostate cancer. A multiparametric prostate MRI was performed to assess 
the possibility of prostate cancer recurrence. TECHNIQUE: Multiplanar, 
multisequence MRI of the abdomen and pelvis was performed, including 
diffusion, T2, and dynamic contrast-enhanced (DCE) imaging of the 
prostate. The post-contrast images were obtained following the 
uneventful intravenous administration of 7 mL of gadobutrol (Gadavist) 
gadolinium-containing contrast. FINDINGS: The prostate gland measures 
4.3 x 4.8 x 4.7 cm (volume 47 mL). A focal area of T2 hypointensity is 
seen in the right mid-gland, measuring approximately 12 x 11 mm in 
diameter. The area shows restricted diffusion on the ADC map, with a 
value of 798 x 10^-3 mm^2/s. The dynamic contrast-enhanced (DCE) 
characteristics show focal enhancing lesion with washout kinetics in the
 right mid-gland, with a PI-RADS v2 score of 5. No other suspicious 
lesions or abnormal signal intensity are seen in the peripheral zone of 
the prostate gland. IMPRESSION: Based on the above findings, a focal 
area of T2 hypointensity with restricted diffusion and washout kinetics 
on DCE suggests the presence of clinically significant cancer in the 
right mid-gland with a PI-RADS v2 score of 5. This finding may indicate 
the possibility of prostate cancer recurrence and requires further 
evaluation and monitoring. The patient will be advised for additional 
biopsy and follow-up by their urologist.</td></tr>
<tr><td bgcolor="#ababab">Structured</td><td ,="" bgcolor="#ffffff" style="white-space: pre-wrap; word-wrap: break-word;"><table border="1"><tbody><tr><th>INDICATION</th><td><table border="1"><tbody><tr><th>DATE</th><td></td></tr><tr><th>SERUM PSA LEVEL</th><td>elevated</td></tr><tr><th>PRIOR BIOPSY</th><td><table border="1"><tbody><tr><th>TYPE</th><td></td></tr><tr><th>DATE</th><td></td></tr><tr><th>RESULTS</th><td></td></tr></tbody></table></td></tr><tr><th>PRIOR THERAPY</th><td><table border="1"><tbody><tr><th>RADIATION</th><td></td></tr><tr><th>HORMONES</th><td></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>TECHNIQUE</th><td><table border="1"><tbody><tr><th>PI RADS COMPLIANT</th><td></td></tr><tr><th>FIELD STRENGTH</th><td></td></tr><tr><th>COILS USED</th><td></td></tr><tr><th>IV CONTRAST ADMINISTRATION</th><td><table border="1"><tbody><tr><th>ROUTE</th><td>intravenous</td></tr><tr><th>RATE</th><td>7 mL of gadobutrol (Gadavist)</td></tr></tbody></table></td></tr><tr><th>PULSE SEQUENCE PARAMETERS</th><td>diffusion, T2, and dynamic contrast-enhanced (DCE) imaging</td></tr></tbody></table></td></tr><tr><th>COMPARISON</th><td></td></tr><tr><th>FINDINGS</th><td><table border="1"><tbody><tr><th>QUALITY</th><td></td></tr><tr><th>PERIPHERAL ZONE</th><td>No other suspicious lesions or abnormal signal intensity seen</td></tr><tr><th>TRANSITION ZONE</th><td></td></tr><tr><th>LESIONS</th><td><table border="1"><thead><tr><th>HEMORRHAGE</th><th>RANK</th><th>ZONE</th><th>SIDE</th><th>POSITION</th><th>IMAGE SERIES NUMBER</th><th>LENGTH</th><th>WIDTH</th><th>HEIGHT</th><th>VOLUME</th><th>PSA DENSITY</th><th>EXTRA PROSTATIC EXTENSION</th><th>PI RADS CATEGORY</th></tr></thead><tbody><tr><td></td><td></td><td>right mid-gland</td><td>right</td><td></td><td></td><td>12 mm</td><td>11 mm</td><td></td><td>47 mL</td><td></td><td></td><td>5</td></tr></tbody></table></td></tr><tr><th>NEUROVASCULAR BUNDLES</th><td><table border="1"><tbody><tr><th>IMPRESSION</th><td></td></tr><tr><th>DISTANCE FROM INDEX LESION</th><td></td></tr></tbody></table></td></tr><tr><th>SEMINAL VESICLES</th><td></td></tr><tr><th>LYMPH NODES</th><td></td></tr><tr><th>BONES</th><td></td></tr><tr><th>OTHER PELVIC ORGANS</th><td></td></tr></tbody></table></td></tr><tr><th>IMPRESSION</th><td><table border="1"><thead><tr><th>LESION NUMBER</th><th>OVERALL PI RADS CATEGORY</th></tr></thead><tbody><tr><td>1</td><td>5</td></tr></tbody></table></td></tr></tbody></table></td></tr>
<tr><td bgcolor="#ababab">Free Text</td><td ,="" bgcolor="#ededed" style="white-space: word-wrap;">MRI
 ABDOMEN AND PELVIS FOR EVALUATION OF THE PROSTATECOMPARISON: ()CLINICAL
 HISTORY: The patient is a 72-year-old male with elevated PSA levels and
 a history of prostate cancer. A multiparametric prostate MRI was 
performed to assess the possibility of extraprostatic extension. 
TECHNIQUE: Multiplanar, multisequence MRI of the abdomen and pelvis was 
performed, including diffusion, T2, and dynamic contrast-enhanced (DCE) 
imaging of the prostate. The post-contrast images were obtained 
following the uneventful intravenous administration of 8 mL of 
gadobutrol (Gadavist) gadolinium-containing contrast. FINDINGS: The 
prostate gland measures 4.1 x 4.3 x 4.6 cm (volume 42 mL). There is a 
focal area of T2 hypointensity in the left mid-gland measuring 
approximately 11 x 9 mm in diameter. The area shows restricted diffusion
 on the ADC map, with a value of 890 x 10^-3 mm^2/s. The dynamic 
contrast-enhanced (DCE) characteristics show focal enhancing lesion with
 washout kinetics in the left mid-gland, with a PI-RADS v2 score of 5. 
The area shows capsular abutment and is likely associated with 
extraprostatic extension. No other suspicious lesions or abnormal signal
 intensity are seen in the peripheral zone of the prostate gland. 
IMPRESSION: Based on the above findings, a focal area of T2 
hypointensity with restricted diffusion and washout kinetics on DCE 
suggests the presence of clinically significant cancer in the left 
mid-gland with a PI-RADS v2 score of 5. The capsular abutment and likely
 extraprostatic extension of the lesion is concerning for prostate 
cancer invasion into surrounding tissues. This finding requires further 
evaluation and monitoring for possible treatment options.</td></tr>
<tr><td bgcolor="#ababab">Structured</td><td ,="" bgcolor="#ffffff" style="white-space: pre-wrap; word-wrap: break-word;"><table border="1"><tbody><tr><th>INDICATION</th><td><table border="1"><tbody><tr><th>DATE</th><td></td></tr><tr><th>SERUM PSA LEVEL</th><td></td></tr><tr><th>PRIOR BIOPSY</th><td><table border="1"><tbody><tr><th>TYPE</th><td></td></tr><tr><th>DATE</th><td></td></tr><tr><th>RESULTS</th><td></td></tr></tbody></table></td></tr><tr><th>PRIOR THERAPY</th><td><table border="1"><tbody><tr><th>RADIATION</th><td></td></tr><tr><th>HORMONES</th><td></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>TECHNIQUE</th><td><table border="1"><tbody><tr><th>PI RADS COMPLIANT</th><td></td></tr><tr><th>FIELD STRENGTH</th><td></td></tr><tr><th>COILS USED</th><td></td></tr><tr><th>IV CONTRAST ADMINISTRATION</th><td><table border="1"><tbody><tr><th>ROUTE</th><td>intravenous</td></tr><tr><th>RATE</th><td>8 mL</td></tr></tbody></table></td></tr><tr><th>PULSE SEQUENCE PARAMETERS</th><td>Multiplanar, multisequence MRI of the abdomen and pelvis, including diffusion, T2, and dynamic contrast-enhanced (DCE) imaging of the prostate.</td></tr></tbody></table></td></tr><tr><th>COMPARISON</th><td></td></tr><tr><th>FINDINGS</th><td><table border="1"><tbody><tr><th>QUALITY</th><td></td></tr><tr><th>PERIPHERAL ZONE</th><td>No other suspicious lesions or abnormal signal intensity are seen in the peripheral zone of the prostate gland.</td></tr><tr><th>TRANSITION ZONE</th><td></td></tr><tr><th>LESIONS</th><td><table border="1"><thead><tr><th>HEMORRHAGE</th><th>RANK</th><th>ZONE</th><th>SIDE</th><th>POSITION</th><th>IMAGE SERIES NUMBER</th><th>LENGTH</th><th>WIDTH</th><th>HEIGHT</th><th>VOLUME</th><th>PSA DENSITY</th><th>EXTRA PROSTATIC EXTENSION</th><th>PI RADS CATEGORY</th></tr></thead><tbody><tr><td></td><td></td><td>left mid-gland</td><td>left</td><td>mid-gland</td><td></td><td>11</td><td>9</td><td></td><td>42</td><td></td><td>likely</td><td>5</td></tr></tbody></table></td></tr><tr><th>NEUROVASCULAR BUNDLES</th><td><table border="1"><tbody><tr><th>IMPRESSION</th><td></td></tr><tr><th>DISTANCE FROM INDEX LESION</th><td></td></tr></tbody></table></td></tr><tr><th>SEMINAL VESICLES</th><td></td></tr><tr><th>LYMPH NODES</th><td></td></tr><tr><th>BONES</th><td></td></tr><tr><th>OTHER PELVIC ORGANS</th><td></td></tr></tbody></table></td></tr><tr><th>IMPRESSION</th><td><table border="1"><thead><tr><th>LESION NUMBER</th><th>OVERALL PI RADS CATEGORY</th></tr></thead><tbody><tr><td>1</td><td>5</td></tr></tbody></table></td></tr></tbody></table></td></tr>
<tr><td bgcolor="#ababab">Free Text</td><td ,="" bgcolor="#ededed" style="white-space: word-wrap;">MRI
 ABDOMEN AND PELVIS FOR EVALUATION OF THE PROSTATECLINICAL HISTORY: A 
69-year-old male patient with an elevated PSA of 4.5 has undergone a 
multiparametric prostate MRI for biopsy planning. COMPARISON: There are 
no previous scans for comparison. FINDINGS: The prostate is found to be 
enlarged, measuring 4.4 x 5.3 x 4.6 cm, with a volume of 56 mL. Three 
lesions have been identified. Lesion L1 is located in the left anterior 
transition zone at the mid gland, not crossing the midline, and measures
 10 x 9 mm. The lesion appears as a focal heterogeneously, moderately T2
 hypointense lesion with circumscribed margins. There is no definite 
extra-prostatic extension or invasive behavior observed. The 
neurovascular bundles are not involved. The lesion has a PI-RADS v1 T2 
score of 2 and a PI-RADS v2 T2 score of 3. The DWI/ADC values show an 
ADC region of interest value of 984 x10 -3 mm 2/s, with a PI-RADS v1 
DWI/ADC score of 5 and a PI-RADS v2 DWI/ADC score of 3. The DCE results 
show a PI-RADS v1 DCE score of 3 and a PI-RADS v2 DCE score of positive.
 The overall PI-RADS v1 Lesion Summary Score is 4, and the PI-RADS v2 
Lesion Summary Score is 3. Lesion R1 is located in the right anterior to
 posterolateral peripheral zone at the mid gland, not crossing the 
midline, and measures 11 x 7 mm. The lesion appears as a focal 
heterogeneously, mildly T2 hypointense lesion with circumscribed 
margins. There is no definite extra-prostatic extension or invasive 
behavior observed. The neurovascular bundles are not involved. The 
lesion has a PI-RADS v1 T2 score of 1 and a PI-RADS v2 T2 score of 2. 
The DWI/ADC values show an ADC region of interest value of 1067 x10 -3 
mm 2/s, with a PI-RADS v1 DWI/ADC score of 5 and a PI-RADS v2 DWI/ADC 
score of 3. The DCE results show a PI-RADS v1 DCE score of 2 and a 
PI-RADS v2 DCE score of negative. The overall PI-RADS v1 Lesion Summary 
Score is 3, and the PI-RADS v2 Lesion Summary Score is 2. Lesion R2 is 
located in the right posterolateral peripheral zone at the base, not 
crossing the midline, and measures 8 x 5 mm. The lesion appears as an 
ovoid heterogeneously, moderately T2 hypointense lesion with partially 
circumscribed, partially indistinct margins. There is no definite 
extra-prostatic extension or invasive behavior observed. The 
neurovascular bundles are not involved. The lesion has a PI-RADS v1 T2 
score of 3 and a PI-RADS v2 T2 score of 3. The DWI/ADC values show an 
ADC region of interest value of 1037 x10 -3 mm 2/s, with a PI-RADS v1 
DWI/ADC score of 5 and a PI-RADS v2 DWI/ADC score of 4. The DCE results 
show a PI-RADS v1 DCE score of 2 and a PI-RADS v2 DCE LCA continue score
 of negative. The overall PI-RADS v1 Lesion Summary Score is 4, and the 
PI-RADS v2 Lesion Summary Score is 4. The peripheral zone of the 
prostate demonstrates uniform high signal intensity on T2 without 
additional abnormalities on diffusion or postcontrast imaging, 
suggesting it is likely benign. The central gland exhibits a 
well-encapsulated whorled appearance, consistent with benign prostatic 
hyperplasia, also indicating that it is likely benign. Examining the 
remaining abdomen and pelvis, the lung bases are clear, and no pleural 
or pericardial effusions are observed. The liver appears normal in 
morphology and signal intensity, with no focal liver lesions identified.
 Conventional hepatic arterial anatomy is present, and the hepatic, 
portal, and superior mesenteric veins are patent. No intra- or 
extrahepatic biliary dilatation is present, and the gallbladder is 
normal without gallstones. The pancreas, adrenal glands, and spleen are 
normal. Bilateral small renal cysts are noted, measuring up to 17 mm in 
the right kidney, with no solid mass or hydronephrosis observed. The 
bowel appears normal. The bladder is trabeculated, consistent with 
chronic bladder outlet obstruction and diverticulosis. The visualized 
aorta is normal in caliber, and the IVC is patent. No enlarged lymph 
nodes are detected in the abdomen or pelvis, and no free fluid is seen 
in the abdomen or pelvis. Multilevel degenerative changes of the spine 
are noted. IMPRESSION: Lesion L1 in the mid region of the central gland 
of the prostate is suspicious for prostate cancer, with a PI-RADSv1 
category 4 and PI-RADSv2 category 3. Lesion R1 in the mid region of the 
central gland of the prostate is equivocal for prostate cancer, with a 
PI-RADSv1 category 3 and PI-RADSv2 category 2. Lesion R2 in the base of 
the peripheral zone of the prostate is suspicious for prostate cancer, 
with a PI-RADSv1 category 4 and PI-RADSv2 category 4.</td></tr>
<tr><td bgcolor="#ababab">Structured</td><td ,="" bgcolor="#ffffff" style="white-space: pre-wrap; word-wrap: break-word;"><table border="1"><tbody><tr><th>INDICATION</th><td><table border="1"><tbody><tr><th>DATE</th><td></td></tr><tr><th>SERUM PSA LEVEL</th><td>4.5</td></tr><tr><th>PRIOR BIOPSY</th><td><table border="1"><tbody><tr><th>TYPE</th><td></td></tr><tr><th>DATE</th><td></td></tr><tr><th>RESULTS</th><td></td></tr></tbody></table></td></tr><tr><th>PRIOR THERAPY</th><td><table border="1"><tbody><tr><th>RADIATION</th><td></td></tr><tr><th>HORMONES</th><td></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>TECHNIQUE</th><td><table border="1"><tbody><tr><th>PI RADS COMPLIANT</th><td></td></tr><tr><th>FIELD STRENGTH</th><td></td></tr><tr><th>COILS USED</th><td></td></tr><tr><th>IV CONTRAST ADMINISTRATION</th><td><table border="1"><tbody><tr><th>ROUTE</th><td></td></tr><tr><th>RATE</th><td></td></tr></tbody></table></td></tr><tr><th>PULSE SEQUENCE PARAMETERS</th><td></td></tr></tbody></table></td></tr><tr><th>COMPARISON</th><td>none</td></tr><tr><th>FINDINGS</th><td><table border="1"><tbody><tr><th>QUALITY</th><td></td></tr><tr><th>PERIPHERAL ZONE</th><td>likely benign</td></tr><tr><th>TRANSITION ZONE</th><td>likely benign</td></tr><tr><th>LESIONS</th><td><table border="1"><thead><tr><th>HEMORRHAGE</th><th>RANK</th><th>ZONE</th><th>SIDE</th><th>POSITION</th><th>IMAGE SERIES NUMBER</th><th>LENGTH</th><th>WIDTH</th><th>HEIGHT</th><th>VOLUME</th><th>PSA DENSITY</th><th>EXTRA PROSTATIC EXTENSION</th><th>PI RADS CATEGORY</th></tr></thead><tbody><tr><td></td><td>L1</td><td>left anterior transition zone</td><td>left</td><td>mid gland</td><td></td><td>10</td><td>9</td><td></td><td></td><td></td><td>no</td><td>PI-RADS v2 3</td></tr><tr><td></td><td>R1</td><td>right anterior to posterolateral peripheral zone</td><td>right</td><td>mid gland</td><td></td><td>11</td><td>7</td><td></td><td></td><td></td><td>no</td><td>PI-RADS v2 2</td></tr><tr><td></td><td>R2</td><td>right posterolateral peripheral zone</td><td>right</td><td>base</td><td></td><td>8</td><td>5</td><td></td><td></td><td></td><td>no</td><td>PI-RADS v2 4</td></tr></tbody></table></td></tr><tr><th>NEUROVASCULAR BUNDLES</th><td><table border="1"><tbody><tr><th>IMPRESSION</th><td>not involved</td></tr><tr><th>DISTANCE FROM INDEX LESION</th><td></td></tr></tbody></table></td></tr><tr><th>SEMINAL VESICLES</th><td></td></tr><tr><th>LYMPH NODES</th><td></td></tr><tr><th>BONES</th><td></td></tr><tr><th>OTHER PELVIC ORGANS</th><td></td></tr></tbody></table></td></tr><tr><th>IMPRESSION</th><td><table border="1"><thead><tr><th>LESION NUMBER</th><th>OVERALL PI RADS CATEGORY</th></tr></thead><tbody><tr><td>L1</td><td>PI-RADS v1 4 and PI-RADS v2 3</td></tr><tr><td>R1</td><td>PI-RADS v1 3 and PI-RADS v2 2</td></tr><tr><td>R2</td><td>PI-RADS v1 4 and PI-RADS v2 4</td></tr></tbody></table></td></tr></tbody></table></td></tr>
<tr><td bgcolor="#ababab">Free Text</td><td ,="" bgcolor="#ededed" style="white-space: word-wrap;">MRI
 ABDOMEN AND PELVIS FOR EVALUATION OF THE PROSTATECLINICAL HISTORY: A 
72-year-old male patient with an elevated PSA of 6.1 has undergone a 
multiparametric prostate MRI for biopsy planning and treatment guidance.
 COMPARISON: There are no previous scans for comparison. FINDINGS: The 
prostate measures 3.8 x 4.6 x 3.9 cm, with a volume of 42 mL. Two 
lesions have been identified. Lesion L1 is located in the left posterior
 peripheral zone at the mid gland, not crossing the midline, and 
measures 12 x 8 mm. The lesion appears as a moderately T2 hypointense 
lesion with irregular margins. No definite extra-prostatic extension or 
invasive behavior is observed, and the neurovascular bundles are not 
involved. The lesion has a PI-RADS v2 T2 score of 4 and a DWI/ADC score 
of 4. The DCE score is positive. The overall PI-RADS v2 Lesion Summary 
Score is 4. Lesion R1 is located in the right transition zone at the 
apex, not crossing the midline, and measures 6 x 4 mm. The lesion 
appears as a mildly T2 hypointense lesion with circumscribed margins. 
There is no definite extra-prostatic extension or invasive behavior 
observed, and the neurovascular bundles are not involved. The lesion has
 a PI-RADS v2 T2 score of 2 and a DWI/ADC score of 3. The DCE score is 
negative. The overall PI-RADS v2 Lesion Summary Score is 3. The 
peripheral and central zones of the prostate appear normal, with no 
additional abnormalities detected. Examining the remaining abdomen and 
pelvis, the lung bases, liver, pancreas, adrenal glands, spleen, bowel, 
and vasculature appear normal. The gallbladder is normal without 
gallstones. Bilateral renal cysts are noted, measuring up to 12 mm in 
the left kidney, with no solid mass or hydronephrosis observed. The 
bladder is trabeculated, consistent with chronic bladder outlet 
obstruction. No enlarged lymph nodes or free fluid are detected in the 
abdomen or pelvis. IMPRESSION: Lesion L1 in the left posterior 
peripheral zone of the prostate is suspicious for prostate cancer, with a
 PI-RADSv2 category 4. Lesion R1 in the right transition zone of the 
prostate is equivocal for prostate cancer, with a PI-RADSv2 category 3.</td></tr>
<tr><td bgcolor="#ababab">Structured</td><td ,="" bgcolor="#ffffff" style="white-space: pre-wrap; word-wrap: break-word;"><table border="1"><tbody><tr><th>INDICATION</th><td><table border="1"><tbody><tr><th>DATE</th><td></td></tr><tr><th>SERUM PSA LEVEL</th><td>6.1</td></tr><tr><th>PRIOR BIOPSY</th><td><table border="1"><tbody><tr><th>TYPE</th><td></td></tr><tr><th>DATE</th><td></td></tr><tr><th>RESULTS</th><td></td></tr></tbody></table></td></tr><tr><th>PRIOR THERAPY</th><td><table border="1"><tbody><tr><th>RADIATION</th><td></td></tr><tr><th>HORMONES</th><td></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>TECHNIQUE</th><td><table border="1"><tbody><tr><th>PI RADS COMPLIANT</th><td></td></tr><tr><th>FIELD STRENGTH</th><td></td></tr><tr><th>COILS USED</th><td></td></tr><tr><th>IV CONTRAST ADMINISTRATION</th><td><table border="1"><tbody><tr><th>ROUTE</th><td></td></tr><tr><th>RATE</th><td></td></tr></tbody></table></td></tr><tr><th>PULSE SEQUENCE PARAMETERS</th><td></td></tr></tbody></table></td></tr><tr><th>COMPARISON</th><td>No previous scans</td></tr><tr><th>FINDINGS</th><td><table border="1"><tbody><tr><th>QUALITY</th><td></td></tr><tr><th>PERIPHERAL ZONE</th><td>Normal</td></tr><tr><th>TRANSITION ZONE</th><td>Normal</td></tr><tr><th>LESIONS</th><td><table border="1"><thead><tr><th>HEMORRHAGE</th><th>RANK</th><th>ZONE</th><th>SIDE</th><th>POSITION</th><th>IMAGE SERIES NUMBER</th><th>LENGTH</th><th>WIDTH</th><th>HEIGHT</th><th>VOLUME</th><th>PSA DENSITY</th><th>EXTRA PROSTATIC EXTENSION</th><th>PI RADS CATEGORY</th></tr></thead><tbody><tr><td></td><td>L1</td><td>left posterior peripheral</td><td>left</td><td>mid gland</td><td></td><td>12</td><td>8</td><td></td><td></td><td></td><td>No definite extra-prostatic extension</td><td>4</td></tr><tr><td></td><td>R1</td><td>right transition</td><td>right</td><td>apex</td><td></td><td>6</td><td>4</td><td></td><td></td><td></td><td>No definite extra-prostatic extension</td><td>3</td></tr></tbody></table></td></tr><tr><th>NEUROVASCULAR BUNDLES</th><td><table border="1"><tbody><tr><th>IMPRESSION</th><td>Not involved</td></tr><tr><th>DISTANCE FROM INDEX LESION</th><td></td></tr></tbody></table></td></tr><tr><th>SEMINAL VESICLES</th><td></td></tr><tr><th>LYMPH NODES</th><td>No enlarged lymph nodes</td></tr><tr><th>BONES</th><td></td></tr><tr><th>OTHER PELVIC ORGANS</th><td>Bladder trabeculated, consistent with chronic bladder outlet obstruction</td></tr></tbody></table></td></tr><tr><th>IMPRESSION</th><td><table border="1"><thead><tr><th>LESION NUMBER</th><th>OVERALL PI RADS CATEGORY</th></tr></thead><tbody><tr><td>L1</td><td>4</td></tr><tr><td>R1</td><td>3</td></tr></tbody></table></td></tr></tbody></table></td></tr>
</tbody>
</table>
</body></html>